Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Autoimmune Disorders01:29

Autoimmune Disorders

415
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
415
T Cell Types and Functions01:24

T Cell Types and Functions

999
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
999
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

125
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
125

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Differentiating obesity with and without prediabetes through skin findings: results from PREVIEW sub-study.

Frontiers in endocrinology·2026
Same author

International development of Investigator Global Assessment scores for pemphigus.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

Skin surface microbiome dynamics in the extremes: Learnings from Antarctica distinct community.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

Standardized indirect immunofluorescence-based detection of dermal-binding autoantibodies in pemphigoid diseases: a prospective international multicentre study.

The British journal of dermatology·2025
Same author

Dermatitis herpetiformis, celiac disease and their impact on women and their families.

Italian journal of dermatology and venereology·2025
Same author

High-frequency ultrasound in the diagnosis of Hidradenitis suppurativa: experience from the Bulgarian HS Expert Centre.

Postepy dermatologii i alergologii·2025

Related Experiment Video

Updated: Jun 23, 2025

Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

10.5K

Artificial intelligence in autoimmune bullous dermatoses.

Karen Manuelyan1, Miroslav Dragolov2, Kossara Drenovska3

  • 1Department of Dermatology and Venereology, Medical Faculty, Trakia University, Stara Zagora, Bulgaria.

Clinics in Dermatology
|June 24, 2024
PubMed
Summary

Artificial intelligence (AI) offers significant potential to improve the diagnosis, treatment, and monitoring of autoimmune bullous dermatoses (AIBDs). AI tools can enhance clinical assessments, personalize patient care, and streamline laboratory diagnostics for these chronic skin conditions.

More Related Videos

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

4.8K
A Chronic Autoimmune Dry Eye Rat Model with Increase in Effector Memory T Cells in Eyeball Tissue
09:42

A Chronic Autoimmune Dry Eye Rat Model with Increase in Effector Memory T Cells in Eyeball Tissue

Published on: June 7, 2017

11.5K

Related Experiment Videos

Last Updated: Jun 23, 2025

Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

10.5K
Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

4.8K
A Chronic Autoimmune Dry Eye Rat Model with Increase in Effector Memory T Cells in Eyeball Tissue
09:42

A Chronic Autoimmune Dry Eye Rat Model with Increase in Effector Memory T Cells in Eyeball Tissue

Published on: June 7, 2017

11.5K

Area of Science:

  • Dermatology
  • Medical Informatics
  • Artificial Intelligence

Background:

  • Autoimmune bullous dermatoses (AIBDs) present complex challenges for dermatologists and patients throughout the care continuum.
  • Current management involves difficulties in assessment, diagnosis, prognosis, treatment, and monitoring.
  • There is a need for innovative solutions to improve patient outcomes and clinical workflows.

Purpose of the Study:

  • To summarize the current and potential future clinical applications of artificial intelligence (AI) in the management of AIBDs.
  • To explore how AI can enhance various stages of AIBD care, from diagnosis to follow-up.
  • To highlight AI's role in supporting clinicians and patients in managing chronic skin diseases.

Main Methods:

  • Review of recent research and existing AI models relevant to AIBDs.
  • Analysis of AI applications in clinical diagnosis, disease severity scoring, and laboratory testing.
  • Discussion of AI's potential impact on personalized treatment and patient management.

Main Results:

  • AI, particularly image recognition, shows promise for precise clinical diagnosis and consistent disease severity scoring in AIBDs.
  • AI-assisted laboratory methods could increase accuracy and reduce the time and cost of diagnostic tests like immunofluorescence.
  • AI tools are emerging as valuable support systems for comprehensive diagnosis and personalized treatment of AIBDs.

Conclusions:

  • AI applications are in early stages but demonstrate potential to significantly advance AIBD care.
  • AI can enhance diagnostic accuracy, treatment personalization, and efficiency in managing AIBDs.
  • AI may herald a transformative shift in managing chronic skin diseases, including AIBDs.